Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2008

01-07-2008 | Hepatic and Pancreatic Tumors

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

Authors: Daniel H. Palmer, PhD, Deborah D. Stocken, MSc, Helen Hewitt, Catherine E. Markham, A. Bassim Hassan, PhD, Philip J. Johnson, MD, John A. C. Buckels, MD, Simon R. Bramhall, MD

Published in: Annals of Surgical Oncology | Issue 7/2008

Login to get access

Excerpt

Authors’ Reply:
Literature
1.
go back to reference Palmer DH, Stocken DD, Hewitt H, et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 2007;14:2088–96.PubMedCrossRef Palmer DH, Stocken DD, Hewitt H, et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 2007;14:2088–96.PubMedCrossRef
2.
go back to reference Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26–9.PubMedCrossRef Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26–9.PubMedCrossRef
Metadata
Title
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer
Authors
Daniel H. Palmer, PhD
Deborah D. Stocken, MSc
Helen Hewitt
Catherine E. Markham
A. Bassim Hassan, PhD
Philip J. Johnson, MD
John A. C. Buckels, MD
Simon R. Bramhall, MD
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9921-2

Other articles of this Issue 7/2008

Annals of Surgical Oncology 7/2008 Go to the issue